Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Dow
Covington
Express Scripts
Fuji
Mallinckrodt
Teva
Johnson and Johnson

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011491

« Back to Dashboard

NDA 011491 describes VESPRIN, which is a drug marketed by Apothecon and Bristol Myers Squibb and is included in three NDAs. Additional details are available on the VESPRIN profile page.

The generic ingredient in VESPRIN is triflupromazine. There are two drug master file entries for this compound. Additional details are available on the triflupromazine profile page.
Summary for 011491
Tradename:VESPRIN
Applicant:Apothecon
Ingredient:triflupromazine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 011491

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrengthEQ 50MG HCL/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Dow
Covington
Farmers Insurance
McKinsey
Citi
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.